Nad(p)h Oxidase Regulates Cyclin D1 and Cdk4 but not P21Cip1 and P27Kip1 - Role in Ang Ii-mediated Growth of Human Vsmcs: P48

Rhian M Touyz,Guoying Yao,Ernesto L Schiffrin
IF: 9.8968
2005-01-01
Hypertension
Abstract:Ang II stimulates growth of vascular smooth muscle cells (VSMC) through NADPH-driven generation of reactive oxygen species (ROS). Molecular mechanisms underlying redoxdependent growth by Ang II remain unclear. The aim of this study was to investigate the role of NADPH oxidase in the regulation of cell cycle modulators in Ang II-stimulated VSMCs. Human VSMCs from resistance arteries were studied. DNA and protein synthesis were assessed by measuring incorporation of H-thymidine and H-leucine respectively. Cell cycle was assessed in propidium iodide-labeled cells by flow cytometry. Cell cycle activators cyclin D1, cyclin E, cyclin-dependent kinase 4 (CDK4) and proliferating cell nuclear antigen (PCNA) (a marker of cell growth) were assessed by immunoblotting. Activation of CDK inhibitors p21 and p27 was determined using phospho-specific antibodies. NAD(P)H oxidase was inhibited with apocynin (10 mol/L). Ang II dose-dependently increased incorporation of H-thymidine (3-fold) and H-leucine (3.8-fold). The proportion of cells in S phase was higher, whereas the proportion of cells in G1 G0 phase was lower, in Ang II-stimulated cells compared with controls. Apocynin inhibited cell growth and reduced PCNA expression by 60%. Ang II increased expression of cyclin D1 (1.3-fold) and CDK4 (1.2-fold), which induce progression from G1 to S phase. Cyclin E was unaffected by Ang II. Apocynin significantly reduced (p 0.05) expression of cyclin D1 and CDK4 with no effect on cyclin E. Phosphorylation of p21 and p27 was significantly reduced (by 40%) in Ang II-stimulated cells and was unaltered by apocynin. These data indicate that Ang II stimulates growth by upregulating the cell cycle activators cyclin D1 and CDK4 and by inhibiting phosphorylation of cell cycle repressors p21 and p27. Whereas cell cycle activators are modulated by NAD(P)H oxidase-derived ROS, CDK inhibitors are not. Our findings suggest that redox-dependent regulation of VSMC growth by Ang II is mediated primarily through cell cycle activators that control progression of the cell cycle from the G1 to S phase.
What problem does this paper attempt to address?